Vapotherm Announces Appointment of Lance Berry to Board of Directors and the Retirement of Neal Armstrong
31 January 2020 - 8:02AM
Business Wire
Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm” or the “Company”), a
global medical technology company focused on the development and
commercialization of its proprietary Hi-VNI® Technology products
that are used to treat patients of all ages suffering from
respiratory distress, today announced the appointment of Lance
Berry to its Board of Directors, and as a member and chair of the
Audit Committee, both effective on January 29, 2020. Mr. Berry
replaces Neal Armstrong, whose retirement was effective upon Mr.
Berry’s appointment.
“We are delighted that Lance is joining our Board of Directors
and will be serving as the Chair of the Audit Committee. Lance’s
significant experience in successfully growing a publicly traded
medical device company will be a highly valuable addition to our
board,” said Joe Army, Vapotherm’s President and CEO. “We welcome
him to the Vapotherm Board of Directors and look forward to working
with him in the years to come.”
Mr. Berry has nearly two decades of financial leadership
experience in the medical device industry. He currently serves as
the Executive Vice President, Chief Financial and Operations
Officer of Wright Medical Group N.V. after serving in a number of
financial leadership positions dating back to 2002. Prior to Wright
Medical, he was an accountant in the auditing division of Arthur
Andersen, LLP, from 1995 to 2002, where he held various positions
of increasing responsibility, most recently as Audit Manager. Mr.
Berry is a Certified Public Accountant and received both a
bachelor’s degree in accounting and his master’s degree in
accounting from the University of Mississippi.
Mr. Armstrong has served on the Board since 2007 and is the
current Chair of the Audit Committee. He is retiring from his
distinguished professional career, highlighted by his time spent as
Chief Financial Officer at Aspect Medical from 1996 to 2005 and in
2009, and at Haemonetics from 1990 to 1996.
"Neal’s guidance has been invaluable to Vapotherm, and we want
to thank him for all that he has done for Vapotherm during his
service. Neal has brought a strong financial management perspective
plus a wealth of executive experience into every board meeting and
has provided leadership and guidance to the Vapotherm team as we
continue to grow our business and drive towards profitability,"
said James Liken, Chairman of the Vapotherm Board of Directors. “We
wish him the very best in his retirement.”
Vapotherm, Inc. (NYSE: VAPO) is a publicly traded
developer and manufacturer of advanced respiratory technology based
in Exeter, New Hampshire, USA. The company develops innovative,
comfortable, non-invasive technologies for respiratory support of
patients with chronic or acute breathing disorders. Over 2.0
million patients have been treated with Vapotherm Hi-VNI
Technology. For more information, visit www.vapotherm.com.
Hi-VNI® Technology is mask-free noninvasive ventilation
for spontaneously breathing patients and a front-line tool for
relieving respiratory distress—including hypercapnia, hypoxemia,
and dyspnea. It allows for the fast, safe treatment of
undifferentiated respiratory distress with one user-friendly tool.
Hi-VNI Technology’s mask-free interface delivers optimally
conditioned breathing gases, making it comfortable for patients and
reducing the risks and care complexities associated with mask
therapies. While being treated, patients can talk, eat, drink and
take oral medication.
Website Information Vapotherm routinely posts important
information for investors on the Investor Relations section of its
website, http://investors.vapotherm.com/. Vapotherm intends to use
this website as a means of disclosing material, non-public
information and for complying with Vapotherm’s disclosure
obligations under Regulation FD. Accordingly, investors should
monitor the Investor Relations section of Vapotherm’s website, in
addition to following Vapotherm’s press releases, Securities and
Exchange Commission filings, public conference calls, presentations
and webcasts. The information contained on, or that may be accessed
through, Vapotherm’s website is not incorporated by reference into,
and is not a part of, this document.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200130005518/en/
Investor Relations Contacts: Mark Klausner or Mike
Vallie, Westwicke, an ICR Company, ir@vtherm.com, +1 (603)
658-0011
Vapotherm (NYSE:VAPO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vapotherm (NYSE:VAPO)
Historical Stock Chart
From Sep 2023 to Sep 2024